Open access · OA via OpenAlex

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach

Antonio Cuadrado, Gina Manda, Ahmed Hassan, María José Alcaraz, Coral Barbas, Andreas Daiber, Pietro Ghezzi, Rafael León, Manuela G. López, Baldo Oliva, Marta Pajares, Ana I. Rojo, Natalia Robledinos-Antón, Ángela M. Valverde, Emre Güney

Pharmacological Reviews · 2018 · ▲ 610 citations

Chronic inflammation

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1124/pr.117.014753
Canonical: link ↗
Fetched: 2026-06-03 MST

Cite this

APA

Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M.J., Barbas, C., Daiber, A., Ghezzi, P., León, R., López, M.G., Oliva, B., Pajares, M., Rojo, A.I., Robledinos-Antón, N., Valverde, �.M., Güney, E., & Schmidt, H. (2018). Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach. <em>Pharmacological Reviews</em>. https://doi.org/10.1124/pr.117.014753

Vancouver

Cuadrado A, Manda G, Hassan A, Alcaraz MJ, Barbas C, Daiber A, et al. Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach. Pharmacological Reviews. 2018. doi:10.1124/pr.117.014753.

BibTeX

@article{antonio2018Transc, title = {Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach}, author = {Antonio Cuadrado and Gina Manda and Ahmed Hassan and María José Alcaraz and Coral Barbas and Andreas Daiber and Pietro Ghezzi and Rafael León and Manuela G. López and Baldo Oliva and Marta Pajares and Ana I. Rojo and Natalia Robledinos-Antón and Ángela M. Valverde and Emre Güney and Harald Schmidt}, journal = {Pharmacological Reviews}, year = {2018}, doi = {10.1124/pr.117.014753}, }